Literature DB >> 7593330

Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane.

C J Carsberg1, K A Myers, G S Evans, T D Allen, P L Stern.   

Abstract

The 5T4 oncofoetal antigen is a 72 kDa glycoprotein defined by a monoclonal antibody raised against human placental trophoblast and is expressed in many different carcinomas but detected only at low levels in some normal epithelia. Immunohistochemical analysis of the patterns of expression in colorectal carcinomas has indicated a significant association between the presence of the antigen in tumour cells and metastatic spread. A cDNA encoding the 5T4 molecules has been isolated and the extracellular portion contains several leucine-rich repeats which have been implicated in cellular interactions. To study the cell biological role of 5T4 molecules, murine L cells (A9 derivative) were stably transfected with 5T4 cDNA under the control of the CMV immediate-early promoter. The 5T4-expressing cells exhibited a more spindle-shaped morphology compared to the vector alone transfected cells. Confocal immunofluorescence microscopy revealed a 'polkadot' pattern of 5T4 antigen expression, heterogeneous in intensity between cells, but distributed over the entire cell surface. Transmission and scanning electron microscopy showed that the 5T4 antigen is concentrated at microvillus projections of the plasma membrane both in the transfected A9 cells and in various carcinoma cell lines. Such projections express an array of surface molecules which function in cell adhesion and motility. This association of 5T4 antigen with microvillus projections was also observed in various carcinoma cell lines. 5T4 expression in A9 cells was also associated with an altered pattern of cell division, decreased cell-substratum adhesion and increased cellular motility. These results support the hypothesis that 5T4 molecules may have a direct function in trophoblast and tumour cell invasion processes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593330     DOI: 10.1242/jcs.108.8.2905

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  11 in total

1.  Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen.

Authors:  David M Shaw; Andrew M Woods; Kevin A Myers; Caroline Westwater; Veena Rahi-Saund; Michael J Davies; David V Renouf; Elizabeth F Hounsell; Peter L Stern
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

2.  Trophoblast Glycoprotein (TPGB/5T4) in Human Placenta: Expression, Regulation, and Presence in Extracellular Microvesicles and Exosomes.

Authors:  S M K Alam; S Jasti; S K Kshirsagar; D S Tannetta; R A Dragovic; C W Redman; I L Sargent; H C Hodes; T L Nauser; T Fortes; A M Filler; K Behan; D R Martin; T A Fields; B K Petroff; M G Petroff
Journal:  Reprod Sci       Date:  2017-05-08       Impact factor: 3.060

3.  Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer.

Authors:  Andrew M Woods; Who W Wang; David M Shaw; Christopher M Ward; Miles W Carroll; Buddug R Rees; Peter L Stern
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

4.  Trophoblast glycoprotein: possible candidate mediating podocyte injuries in glomerulonephritis.

Authors:  Taichi Murakami; Hideharu Abe; Kojiro Nagai; Tatsuya Tominaga; Norimichi Takamatsu; Toshikazu Araoka; Seiji Kishi; Toshikazu Takahashi; Akira Mima; Yoshimi Takai; Jeffrey B Kopp; Toshio Doi
Journal:  Am J Nephrol       Date:  2010-10-27       Impact factor: 3.754

5.  Identification of PKCα-dependent phosphoproteins in mouse retina.

Authors:  Colin M Wakeham; Phillip A Wilmarth; Jennifer M Cunliffe; John E Klimek; Gaoying Ren; Larry L David; Catherine W Morgans
Journal:  J Proteomics       Date:  2019-06-28       Impact factor: 4.044

6.  GIPC1 interacts with MyoGEF and promotes MDA-MB-231 breast cancer cell invasion.

Authors:  Di Wu; Akiko Haruta; Qize Wei
Journal:  J Biol Chem       Date:  2010-07-15       Impact factor: 5.157

7.  CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells.

Authors:  Thomas D Southgate; Owen J McGinn; Fernanda V Castro; Andrzej J Rutkowski; Mariam Al-Muftah; Georgi Marinov; Graeme J Smethurst; David Shaw; Christopher M Ward; Crispin J Miller; Peter L Stern
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer.

Authors:  Gemma L Owens; Victoria E Sheard; Milena Kalaitsidou; Daniel Blount; Yatish Lad; Eleanor J Cheadle; Richard J Edmondson; Gurdeep Kooner; David E Gilham; Richard Harrop
Journal:  J Immunother       Date:  2018-04       Impact factor: 4.456

9.  Can urinary exosomes act as treatment response markers in prostate cancer?

Authors:  Paul J Mitchell; Joanne Welton; John Staffurth; Jacquelyn Court; Malcolm D Mason; Zsuzsanna Tabi; Aled Clayton
Journal:  J Transl Med       Date:  2009-01-12       Impact factor: 5.531

10.  Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy.

Authors:  R W Griffiths; D E Gilham; A Dangoor; V Ramani; N W Clarke; P L Stern; R E Hawkins
Journal:  Br J Cancer       Date:  2005-09-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.